secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axsome Therapeutics, Inc. (AXSM)
CIK:        0001579428
Form:       8-K
Filed at:   2022-11-14T23:59:59+00:00
Accession:  0000950170-22-025086
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axsome completes final closing of Sunosi acquisition from Jazz Pharmaceuticals on Nov 14, 2022
--------------------------------------------------------------------------------

- Final closing of ex-U.S. assets for Sunosi occurred Nov 14, 2022, satisfying closing conditions.
- Initial U.S. closing had occurred on May 9, 2022, as previously reported.
- Acquisition covers worldwide rights to Sunosi excluding 12 Asian markets (e.g., China, Korea, Japan).
- Financial statements and pro forma information were previously filed on July 21, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1579428/000095017022025086/0000950170-22-025086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1579428/000095017022025086/axsm-20221114.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-025086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer